The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.18/5111 |
Resumo: | Alternative pre-mRNA splicing (AS) affects gene expression as it generates proteome diversity. Nonsense-mediated mRNA decay (NMD) is a surveillance pathway that recognizes and selectively degrades mRNAs carrying premature translation-termination codons (PTCs), preventing the production of truncated proteins that could result in disease. Several studies have also implicated NMD in the regulation of steady-state levels of physiological mRNAs. In addition, it is known that several regulated AS events do not lead to generation of protein products, as they lead to transcripts that carry PTCs and thus, they are committed to NMD. Indeed, an estimated one-third of naturally occurring, alternatively spliced mRNAs is targeted for NMD, being AS coupled to NMD (AS-NMD) an efficient strategy to regulate gene expression. In this review, we will focus on how AS mechanism operates and how can be coupled to NMD to fine-tune gene expression levels. Furthermore, we will demonstrate the physiological significance of the interplay among AS and NMD in human disease, such as cancer and neurological disorders. The understanding of how AS-NMD orchestrates expression of vital genes is of utmost importance for the advance in diagnosis, prognosis and treatment of many human disorders. |
id |
RCAP_28d89f4a1ef4e3e9c6ef59ccac8f721e |
---|---|
oai_identifier_str |
oai:repositorio.insa.pt:10400.18/5111 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
The role of alternative splicing coupled to nonsense-mediated mRNA decay in human diseaseAS Coupled to NMD (AS-NMD)Alternative Splicing (AS)Human DiseaseNonsense-mediated mRNA Decay (NMD)Post-transcriptional cControl of Gene ExpressionGenómica Funcional e EstruturalExpressão GénicaAlternative pre-mRNA splicing (AS) affects gene expression as it generates proteome diversity. Nonsense-mediated mRNA decay (NMD) is a surveillance pathway that recognizes and selectively degrades mRNAs carrying premature translation-termination codons (PTCs), preventing the production of truncated proteins that could result in disease. Several studies have also implicated NMD in the regulation of steady-state levels of physiological mRNAs. In addition, it is known that several regulated AS events do not lead to generation of protein products, as they lead to transcripts that carry PTCs and thus, they are committed to NMD. Indeed, an estimated one-third of naturally occurring, alternatively spliced mRNAs is targeted for NMD, being AS coupled to NMD (AS-NMD) an efficient strategy to regulate gene expression. In this review, we will focus on how AS mechanism operates and how can be coupled to NMD to fine-tune gene expression levels. Furthermore, we will demonstrate the physiological significance of the interplay among AS and NMD in human disease, such as cancer and neurological disorders. The understanding of how AS-NMD orchestrates expression of vital genes is of utmost importance for the advance in diagnosis, prognosis and treatment of many human disorders.This work was partially supported by Fundação para a Ciência e a Tecnologia (PTFC/BIM-MEC/3749/2014 to LR and UID/MULTI/04046/2013 to BioISI from FCT/MCTES/PIDDAC. Paulo Costa and Juliane Menezes were supported by fellowships from Fundação para a Ciência e a Tecnologia (SFRH/BD/52495/2014 and SFRH/BPD/98360/2013, respectively).ElsevierRepositório Científico do Instituto Nacional de Saúdeda Costa, PauloMenezes, JulianeRomão, Luísa2021-07-23T00:30:12Z2017-102017-10-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.18/5111engInt J Biochem Cell Biol. 2017 Oct;91(Pt B):168-175. doi: 10.1016/j.biocel.2017.07.013. Epub 2017 Jul 221357-272510.1016/j.biocel.2017.07.013info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-20T15:40:40Zoai:repositorio.insa.pt:10400.18/5111Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T18:39:49.962648Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease |
title |
The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease |
spellingShingle |
The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease da Costa, Paulo AS Coupled to NMD (AS-NMD) Alternative Splicing (AS) Human Disease Nonsense-mediated mRNA Decay (NMD) Post-transcriptional cControl of Gene Expression Genómica Funcional e Estrutural Expressão Génica |
title_short |
The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease |
title_full |
The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease |
title_fullStr |
The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease |
title_full_unstemmed |
The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease |
title_sort |
The role of alternative splicing coupled to nonsense-mediated mRNA decay in human disease |
author |
da Costa, Paulo |
author_facet |
da Costa, Paulo Menezes, Juliane Romão, Luísa |
author_role |
author |
author2 |
Menezes, Juliane Romão, Luísa |
author2_role |
author author |
dc.contributor.none.fl_str_mv |
Repositório Científico do Instituto Nacional de Saúde |
dc.contributor.author.fl_str_mv |
da Costa, Paulo Menezes, Juliane Romão, Luísa |
dc.subject.por.fl_str_mv |
AS Coupled to NMD (AS-NMD) Alternative Splicing (AS) Human Disease Nonsense-mediated mRNA Decay (NMD) Post-transcriptional cControl of Gene Expression Genómica Funcional e Estrutural Expressão Génica |
topic |
AS Coupled to NMD (AS-NMD) Alternative Splicing (AS) Human Disease Nonsense-mediated mRNA Decay (NMD) Post-transcriptional cControl of Gene Expression Genómica Funcional e Estrutural Expressão Génica |
description |
Alternative pre-mRNA splicing (AS) affects gene expression as it generates proteome diversity. Nonsense-mediated mRNA decay (NMD) is a surveillance pathway that recognizes and selectively degrades mRNAs carrying premature translation-termination codons (PTCs), preventing the production of truncated proteins that could result in disease. Several studies have also implicated NMD in the regulation of steady-state levels of physiological mRNAs. In addition, it is known that several regulated AS events do not lead to generation of protein products, as they lead to transcripts that carry PTCs and thus, they are committed to NMD. Indeed, an estimated one-third of naturally occurring, alternatively spliced mRNAs is targeted for NMD, being AS coupled to NMD (AS-NMD) an efficient strategy to regulate gene expression. In this review, we will focus on how AS mechanism operates and how can be coupled to NMD to fine-tune gene expression levels. Furthermore, we will demonstrate the physiological significance of the interplay among AS and NMD in human disease, such as cancer and neurological disorders. The understanding of how AS-NMD orchestrates expression of vital genes is of utmost importance for the advance in diagnosis, prognosis and treatment of many human disorders. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-10 2017-10-01T00:00:00Z 2021-07-23T00:30:12Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.18/5111 |
url |
http://hdl.handle.net/10400.18/5111 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Int J Biochem Cell Biol. 2017 Oct;91(Pt B):168-175. doi: 10.1016/j.biocel.2017.07.013. Epub 2017 Jul 22 1357-2725 10.1016/j.biocel.2017.07.013 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Elsevier |
publisher.none.fl_str_mv |
Elsevier |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799132138484793344 |